Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-inferiority study of conjugated estrogen tablets from different manufacturers in postmenopausal women
ACTRN12610000119099Phase 3Not yet recruiting
- Sponsor
- Lek
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of conjugated estrogens in Menopausal and Postmenopausal Disorders (2 arms), sponsored by Lek. Primary endpoints: Endometrial thickness and Gynecological clinical examination changes. Planned start Mar 2010; status: not yet recruiting.
02
Drugs
conjugated estrogens
03
Conditions
Menopausal and Postmenopausal Disorders
Beyond the preview
Go deeper on ACTRN12610000119099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000119099.